Noah has been personally and professionally involved in the probiotic/prebiotic, microbiome, genomic and personalized health space for the past seven years.  Recently, leading strategic, product development, regulatory and R&D engagements with established category leading companies to emerging growth start-ups.  In the microbiome space, projects have ranged from advising private-equity, VC, biotechs on microbiome investment/pipeline/industry trends in support of recent acquisitions, developing R&D strategy for emerging microbiome CPG beverages to collaborating with one of the leading global probiotic brands on brand strategy initiatives.  Genomic and personalized health sector engagements have focused on industry intelligence, sales channel positioning, product development and scientific due diligence for DTC genetic or microbiome-based tests with clients ranging from leading companies to emerging growth start-ups.